Junshi Biosciences Major Shareholders Plan to Reduce Stakes

Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877) has released an update.

Shanghai Junshi Biosciences Co., Ltd. has disclosed plans for a reduction in shareholding by major shareholders owning more than 5% of the company’s shares. The two primary shareholders, Shanghai Tanying and Shanghai Tanzheng, hold a combined 8% of Junshi Biosciences, with the shares already available for trading since July 2021. The board and directors assure the announcement’s accuracy and accept legal responsibility for its contents.

For further insights into HK:1877 stock, check out TipRanks’ Stock Analysis page.